Sort
82,697 grants matching “vaccine development”
Mechanisms of Effective Humoral Immune Responses to HIV-1
$885,858Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Partnership for Detection of Infection by Category B Pathogens
$885,818Frances S. Ligler · U.S. Naval Research Laboratory · U01 · FY2007 · AI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite
$885,500Kevin Wiehe · University Of Pennsylvania · P01 · FY2023 · AI
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
$885,500Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2023 · AI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite
$885,499Kevin Wiehe · University Of Pennsylvania · P01 · FY2024 · AI
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
$885,499Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2024 · AI
CELL BIOLOGY OF MYCOBACTERIUM AVIUM INFECTION
$885,440University Of California San Francisco · P01 · FY2000 · AI
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
$885,403Wu-Bo Li · Functional Genetics, Inc. · R44 · FY2010 · AI
Strategies for Prevention of Autoimmunity
$885,307Stanford University · U19 · FY2003 · DK
Pediatric AIDS Clinical Trials Group
$885,194University Of California San Diego · U01 · FY2003 · AI
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
$885,192S Munir Alam · Duke University · R01 · FY2023 · AI
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
$885,192S Munir Alam · Duke University · R01 · FY2020 · AI
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
$885,192S Munir Alam · Duke University · R01 · FY2021 · AI
Inhibitors of Anthrax Lethal Factor Metalloproteinase
$885,095Alan Thomas Johnson · Panthera Biopharma, Llc · R44 · FY2007 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$885,028Marie Bleakley · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually
$885,000Chris Beyrer · Ias · R13 · FY2022 · AI
Cooperative Research Partnership for an Amebic Colitis Vaccine
$884,930William A Petri · University Of Virginia · U01 · FY2006 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$884,886John Ross Teijaro · Scripps Research Institute, The · R01 · FY2024 · AI
Developing and Testing a Multi-level Package of Interventions for an Integrated Care Delivery Model of HIV Prevention and Treatment Targeting Adolescent Girls in Zambia
$884,812Sujha Subramanian · Research Triangle Institute · UG3 · FY2018 · HD
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis
$884,638Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2024 · AI
Host-pathogen interactions in filarial worm infections
$884,615Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Project 1
$884,500Robert F Garry · Scripps Research Institute, The · U19 · FY2023 · AI
Immunotherapeutic Approaches for AIDS
$884,441George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$884,388Daniel E Kahne · Harvard Medical School · U19 · FY2018 · AI
TULANE/LSU PEDIATRIC AIDS CLINICAL TRIALS UNIT
$884,360Tulane University Of Louisiana · U01 · FY2001 · AI